je.st
news
Pfizer's Stock Price Is Scheduled To Pop
2016-02-21 12:58:32| Biotech - Topix.net
On the 3rd of February of 2015, the Food and Drug Administration granted the "accelerated approval to Ibrance to treat advanced breast cancer." The FDA decided to grant Ibrance breakthrough therapy designation, "because the sponsor demonstrated through preliminary clinical evidence that the drug may offer a substantial improvement over available therapies."
Tags: price
stock
pop
scheduled
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||